Suppr超能文献

阿扎胞苷诱导人乳腺癌MCF7细胞对多柔比星的化学敏感性

Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.

作者信息

Khan Gul Nabi, Kim Eun Jin, Shin Tae Seop, Lee Sang Ho

机构信息

Division of Life Sciences, Korea University, Seoul, Republic of Korea.

Division of Life Sciences, Korea University, Seoul, Republic of Korea

出版信息

Anticancer Res. 2017 May;37(5):2355-2364. doi: 10.21873/anticanres.11573.

Abstract

BACKGROUND/AIM: It is necessary to select an appropriate strategy that makes cancer cells more sensitive to chemotherapeutic drug(s). The aim of this study was to further explore the mechanism(s) behind drug sensitization in the breast cancer MCF7 cell line using 5-azacytidine (AzaC) pretreatment in doxorubicin (Dox) chemotherapy.

MATERIALS AND METHODS

Cells were treated with either AzaC or Dox alone or in combination (AzaC+Dox) for 24 and 48 h. Cells were also pretreated with AzaC for a week before replacement with Dox at varying concentrations in another group of experiments (AzaC/Dox) for 24 and 48 h. The cells in the groups were subjected to cytochemical analyses, including 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazoliumbromide (MTT), intracellular reactive oxygen species (ROS) and cell death by dual staining with Hoechst33342 (Hoechst) and propidium iodide (PI). Cells were also analyzed for determining specific alterations of possible target proteins by western blot.

RESULTS

Compared to a single (AzaC and Dox) or simultaneous drug exposure (AzaC+Dox), cellular activity was significantly reduced in AzaC/Dox group of cells in a dose- and time-dependent manner (p<0.05). The clonogenic potential of cells was also significantly inhibited in AzaC/Dox compared to Dox and AzaC group after 7 days (p<0.05). The rates of ROS-generated and PI-stained cells were significantly higher in the AzaC+Dox and AzaC/Dox groups compared to those of individual drug groups at 48 h (p<0.05). These observations were accompanied by activation of ERK1/2 and p38MAPK, as well as up-regulation of BAX and P53 in the AzaC/Dox group. However, the levels of BCL-2 were down-regulated in Dox and AzaC+Dox among a different group of cells. Elevated levels of activated caspase-3 were observed only in AzaC/Dox group of cells. The levels of phospho-nuclear factor-kappa B (pNF-ĸB)(Thr) decreased with increasing dosage of Dox in different groups, while down-regulation of heat shock protein 70 (HSP70) was observed only in the AzaC+Dox group of cells.

CONCLUSION

AzaC significantly increases the sensitivity of MCF7 cells to Dox via activation of ERK1/2, P53, BAX and caspase-3. Moreover, the inhibition of pNF-ĸB(Thr) and HSP70 might also contribute to an increase in the sensitivity of MCF7 cells to Dox.

摘要

背景/目的:有必要选择一种合适的策略,使癌细胞对化疗药物更敏感。本研究的目的是使用5-氮杂胞苷(AzaC)预处理联合阿霉素(Dox)化疗,进一步探讨乳腺癌MCF7细胞系中药物致敏背后的机制。

材料与方法

细胞单独用AzaC或Dox处理,或联合处理(AzaC+Dox)24小时和48小时。在另一组实验中(AzaC/Dox),细胞先用AzaC预处理一周,然后用不同浓度的Dox替换,处理24小时和48小时。对各组细胞进行细胞化学分析,包括3-(4,5-二甲基-2-噻唑基)-2,5-二苯基-2H-四唑溴盐(MTT)、细胞内活性氧(ROS)以及用Hoechst33342(Hoechst)和碘化丙啶(PI)双重染色检测细胞死亡情况。还通过蛋白质印迹法分析细胞,以确定可能的靶蛋白的特异性改变。

结果

与单一(AzaC和Dox)或同时药物暴露(AzaC+Dox)相比,AzaC/Dox组细胞的细胞活性以剂量和时间依赖性方式显著降低(p<0.05)。与Dox和AzaC组相比,7天后AzaC/Dox组细胞的克隆形成潜力也显著受到抑制(p<0.05)。在48小时时,AzaC+Dox组和AzaC/Dox组中ROS生成细胞率和PI染色细胞率显著高于单一药物组(p<0.05)。这些观察结果伴随着AzaC/Dox组中ERK1/2和p38MAPK的激活,以及BAX和P53的上调。然而,在另一组不同的细胞中,Dox和AzaC+Dox组中BCL-2水平下调。仅在AzaC/Dox组细胞中观察到活化的caspase-3水平升高。不同组中磷酸化核因子-κB(pNF-κB)(Thr)水平随Dox剂量增加而降低,而仅在AzaC+Dox组细胞中观察到热休克蛋白70(HSP70)下调。

结论

AzaC通过激活ERK1/2、P53、BAX和caspase-3,显著增加MCF7细胞对Dox的敏感性。此外,pNF-κB(Thr)和HSP70的抑制也可能有助于增加MCF7细胞对Dox的敏感性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验